Wills Eye Institute - Ocular Oncology Service — Philadelphia, Pennsylvania

Wills Eye Institute - Ocular Oncology Service is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Wills Eye Institute - Ocular Oncology Service has participated in 1 clinical trials.

Therapeutic areas: Leber Hereditary Optic Neuropathy.

Sponsors: GenSight Biologics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wills Eye Institute - Ocular Oncology Service?

Wills Eye Institute - Ocular Oncology Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wills Eye Institute - Ocular Oncology Service conducted?

Wills Eye Institute - Ocular Oncology Service has 1 clinical trials on record. Their work covers Leber Hereditary Optic Neuropathy.

Is Wills Eye Institute - Ocular Oncology Service accredited by Crixeo Health?

Wills Eye Institute - Ocular Oncology Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wills Eye Institute - Ocular Oncology Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.